Clinical Trials Directory

Trials / Terminated

TerminatedNCT00004728

Aspirin Or Warfarin To Prevent Stroke

Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS) · NIH
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether aspirin or warfarin is more effective in preventing stroke in patients with intracranial stenosis.

Detailed description

Prevention of stroke in patients with narrowing of one of the arteries in the brain typically consists of using medications to prevent blood clots from forming. Currently, the best medication to use in this situation is unknown. The purpose of this study is to compare the effectiveness of two different medications, warfarin or aspirin, for the prevention of stroke due to narrowing of one of the large arteries in the brain. Patients must have experienced a recent transient ischemic attack (TIA) or mild stroke. Stroke of this type is thought to occur more often in minorities.

Conditions

Interventions

TypeNameDescription
DRUGWarfarin
DRUGAspirin

Timeline

Completion
2003-07-01
First posted
2000-02-28
Last updated
2006-06-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00004728. Inclusion in this directory is not an endorsement.